Lancashire and South Cumbria
Formulary
 
back
8 Malignant disease and immunosuppression

The majority of systemic anti-cancer therapies are not listed in this formulary as they are included in either the Lancashire and South Cumbria Cancer Alliance SACT protocols or the Cancer Drugs Fund list, produced by NHSE. 
08-02-01 Antiproliferative immunosuppressants

Azathioprine
Formulary

Tablets 25mg, 50mg

Amber 2 Inflammatory bowel disease, Rheumatic diseases, Dermatology.

Amber 1 Myasthenia Gravis.

Red Transplant rejection.

See section 01.05.03 and 13.05.03.
Link  LSCMMG: Shared care guideline - Azathioprine

Cytotoxic Drug  View adult BNF  View SPC online  View childrens BNF
Mycophenolate Mofetil
Formulary

Capsules 250mg

Tablets 500mg
Oral suspension 1g/5mL

Red Traffic Light Cellcept® for transplant patients only.
Amber 0 Generic prescribing for dermatology use.

Red Complex pain syndrome.
Link  LSCMMG: Shared care guideline: Mycophenolate Mofetil
Link  MHRA: Mycophenolate mofetil, mycophenolic acid: new pregnancy-prevention advice for women and men
Link  MHRA: Mycophenolate mofetil, mycophenolic acid: updated contraception advice for male patients
Link  NICE TA481: Immunosuppressive therapy for kidney transplant in adults
Link  NICE TA482: Immunosuppressive therapy for kidney transplant in children and young people

Amber 1 View adult BNF  View SPC online  View childrens BNF